Allinky Biopharma at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Allinky Biopharma at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
allinky.com
Biotech
Develops oral small-molecule allosteric inhibitors for chronic inflammation, fibrosis and cancer, led by an oral inhibitor of IL-1β production.
Panel
Wed Nov 11
10:30–10:55
Building a Clinical Strategy for First-in-Class Therapeutics
How bold phase 3 trial designs, such as adaptive trials that change as data arrive, can help a first-of-its-kind rare disease drug succeed.
with NMD Pharma, Cellula Therapeutics

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Allinky Biopharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction